Novo's pioneering diabetes pill beats Victoza, Januvia in tests
WSAU News COPENHAGEN (Reuters) - Novo Nordisk's experimental diabetes pill, which it hopes will transform the diabetes market, has proved superior to both Merck & Co's Januvia and its own best-selling injectable treatment Victoza in tests. The positive results ... |
from diabetes - Google News
Social Plugin